ArticleCancer gene therapy2003

A "combination oligonucleotide" antisense strategy to downregulate thymidylate synthase and decrease tumor cell growth and drug resistance.

Randal W Berg et al.PubMed ↗Publisher ↗

No numbers read from the abstract.